Indeed, miR-210 has been shown to promote cell survival by targeting caspase-8-associated protein 2 in rat mesenchymal stem cells [84], E2F3 transcription factor in human pulmonary artery smooth muscle cell [85] and apoptosis-inducing factor, mitochondrion-associated, 3 (AIFM3) in hypoxic human hepatoma cells [86]. This evidence concerns the gene CASP8AP2 and hepatocellular carcinoma.